Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

PE Interest In Hisun's Biosimilars Arm As Hong Kong Firm Acquires $540m Majority Stake

12 Sep 2019

• By Penelope MacRae

Related Content

Humira Biosimilars Face Complex Asia Outlook As Launches Edge Closer

07 Dec 2018

Related Companies

Zhejiang Hisun Pharmaceutical Co. Ltd.

AbbVie Inc.

Roche Holding AG

Additional Topics

China Asia Pacific Business Strategies Commercial M & A BioPharmaceutical

More from China

More from Focus On Asia

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.